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Background: The debate surrounding the use of crystalloids versus colloids remains a source of
controversy due to limited and conflicting evidence. Emerging data favors the use of crystalloids over
colloids in addition to cost benefits. Baptist Hospital of Miami (BHM) has evidence-based guidance for
albumin 5%, but it is unclear the degree of appropriate usage. The purpose of this study is to assess the
prescribing practices of albumin 5% at BHM and optimize appropriate use through pharmacy driven
interventions.
Methodology: A single-center, IRB-reviewed, bi-phasic study was conducted within a community
hospital. In phase I, a retrospective chart review of patients who received albumin 5% during 2019 was
conducted to evaluate prescribing patterns. Phase II was performed after pharmacy driven education
was completed to increase appropriate use. A pharmacist was on-call for the prospective chart review to
assess appropriateness of albumin 5% orders in patients who met inclusion criteria. The primary
outcome is the comparison of appropriate usage of albumin 5% before and after education. Secondary
outcomes include pharmacist interventions and the financial impact.
Results: After implementation of the albumin 5% stewardship initiative, inappropriate use of albumin
5% was decreased significantly by 54%. Through the 30-day interventional phase, a total of 13 pharmacy
interventions were performed with 100% acceptance rate including optimization of crystalloid
resuscitation or discontinuation of fluids completely. These interventions along with provider education
resulted in at least 72 albumin 5% doses avoided during the phase II study period, which amounts to an
extrapolated annual cost savings of ~ $32,400.
Conclusion: Introduction of evidence-based guidance in conjugation with prospective pharmacist review
and intervention can facilitate the optimization of albumin 5% use. These results demonstrate shifting
towards a more evidence-based practice, which ultimately will increase patient’s safety and enhance
quality of care.

